Repro Med Systems Inc (REPR)

[mrholty]

I'd like to think that is a precursor of future sales but I'm not convinced. Historically there hasn't been a good correlation of future sales as compared to inventory.

I'd really love to figure out what the increase in Property, Plant and Equipment was for. Its only a $300k increase but for them its a pretty big jump. I'd love to find out if for warehousing or a sales office somewhere. While I'm asking for more details I also want to get a breakdown of sales by region. For several quarters they have stated the majority of their SG&A increase is due to sales staff in Europe but I can't get any idea of any traction over there at all. Hopefully the increase in SG&A drives sales demand which drove the need for a warehouse in Europe which accounts for the increase in inventory.

I still cannot figure out why they sold 1M shares in a private offering as the have a strong balance sheet and don't seem to need the cash.

Their increase in R&D should be interesting to see what comes from it. I usually think it takes 2 years to get to market and the R&D increase has only been for 2 quarters.

BTW, the results are better than the earnings from GLGI.